HER2 Mutations Breast Neoplasms
2 clinical trials · Condition
◉ Watch HER2 Mutations Breast Neoplasms
| Record | Firm | Date |
|---|---|---|
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations (NCT04579380) | Seagen, a wholly owned subsidiary of Pfizer | 2021-01-11 |
| A Safety Study of SGN-LIV1A in Breast Cancer Patients (NCT01969643) | Seagen Inc. | 2013-10-22 |
Track HER2 Mutations Breast Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.